What is the most important question about gummy manufacturing that has been answered by a different industry but not yet transferred here?

The most important question that has been definitively answered in another industry but not yet fully transferred to gummy manufacturing is: "How do we ensure uniform active ingredient distribution throughout the entire batch, from first gummy to last?"

In the pharmaceutical tablet and capsule industry, this question was solved decades ago with rigorous blending protocols, content uniformity testing, and in-line process controls. Yet many gummy manufacturers-especially those newer to the space-still rely on outdated methods like "add the active last and mix gently" or worse, no formal blending validation at all. The result: gummy batches where the first few gummies may contain far more or far less of the active ingredient than later ones, leading to product inconsistency and potential regulatory risk.

Why This Answer Hasn't Transferred Fully

Several factors have slowed the transfer of this pharmaceutical-grade solution to gummy manufacturing:

• Perception of gummies as "simple candy": Many supplement makers treat gummies more like confectionery than a delivery system for active ingredients.
• Lack of standardized equipment: Gummy production lines often lack the sophisticated mixing and sampling ports found in tablet or capsule manufacturing.
• Ingredient challenges: Active ingredients (vitamins, minerals, botanicals) can stick to equipment or settle during the long cooling process, making uniform distribution harder.

The Solution That Needs to Be Adopted

To bring gummy manufacturing up to pharmaceutical standards, manufacturers should adopt these proven practices from solid-dose manufacturing:

1. Rigorous blending validation: Use geometric dilution (for low-dose actives) followed by tumbling or high-shear mixing to ensure homogeneity before depositing into molds.
2. In-process sampling: Pull samples from the beginning, middle, and end of each production run for potency testing-not just the end.
3. Process control during cooling: Monitor temperature and retention time in cooling tunnels to prevent settling of heavy ingredients (like zinc or magnesium).
4. Content uniformity testing per USP <905>: Use the same statistical criteria demanded for tablets and capsules, not a relaxed gummy-specific standard.

At KorNutra, we have implemented these exact protocols from pharmaceutical manufacturing to ensure every gummy in our batches delivers the labeled amount of active ingredient. We never mention other manufacturers, but we can confirm that the industry as a whole still has significant room for improvement in this area. The question is simple: Are your gummies truly uniform from first to last? If you don't have an answer with data, you likely have a problem that needs fixing.